Related Experiment Video

Updated: Aug 21, 2026

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

[Prognostic factors in advanced ovarian cancer patients]

Katsuhiko Terasawa1, Satoru Sagae

  • 1Department of Obstetrics and Gynecology, Sapporo Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 13, 2004
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Experiment Videos

Last Updated: Aug 21, 2026

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Articles linked to this work by shared authors, journal, and citation graph.

Gestational choriocarcinoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2023

Improvement in radiation techniques for locally advanced cervical cancer during the last two decades.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2023

Endometrial carcinosarcoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2022

Clear cell carcinoma of the endometrium.

Gynecologic oncology·2022

[A feasibility study on cervical screening in non-attenders invited to undergo HPV self-sampling with cytology triage versus repeat invitation for cytology screening in Hokkaido].

[Nihon koshu eisei zasshi] Japanese journal of public health·2021

Uterine serous carcinoma.

Gynecologic oncology·2021

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer.

Molecular oncology·2026

Dynamic multimodal survival prediction in multiple myeloma integrating gene expression, longitudinal laboratory measurements, and treatment history.

Briefings in bioinformatics·2026

p16 Overexpression and Human Papillomavirus Positivity in More Than 1000 Penile Cancers.

International journal of cancer·2026

Effect of Functional Groups Introduced into Radioiodinated Asymmetric Cyanine Dyes on Their In Vivo Behavior.

Molecular pharmaceutics·2026

Unnatural Amino Acid Substitutions to Improve In Vivo GRPR-Targeting Capability of [68Ga]Ga-SP01011 for Cancer Imaging.

Molecular pharmaceutics·2026

18F-FDG PET/CT-based recurrence patterns and survival outcomes in esophageal carcinoma: a single center experience.

Radiology and oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us